Drug Search Results
More Filters [+]

HCP-1401

Alternative Names: hcp-1401, hcp1401, hcp 1401
Latest Update: 2020-02-03
Latest Update Note: Clinical Trial Update

Product Description

For Hypertension (Sourced from: https://clinicaltrials.gov/ct2/show/NCT02916602)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Hanmi Company Limited
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for HCP-1401

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Hypertension

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

HM-ALCH-301

P3

Completed

Hypertension

2016-09-01

HM-ALCH-102

P1

Completed

Healthy Volunteers

2015-11-01

27%

HM-ALCH-102

P1

Completed

Healthy Volunteers

2015-11-01

27%

Recent News Events

Date

Type

Title